Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Early Drug Development Summit 2012

03 Dec 2012 - 04 Dec 2012 - Berlin, Germany



Bookmark and Share


The Early Drug Development Summit is taking place on 3rd-4th December 2012 at the Hotel Palace Berlin, Germany. 

This leading industry summit brings early drug developers together to discuss maximising drug investments, toxicology, safety and biomarkers.  

How should companies address strategies and tools to fully optimise their drug development trajectory to bringing safe, effective and commercially viable drugs to market faster whilst achieving regulatory approval? 

•         Andreas Schneider, Vice President Life Science Alliances, Roche - 

Maximising drug investments by effectively managing early drug development pipelines through the use of knowledge management.

•         Dr Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer HealthCare 

Obtaining grants for biomarkers – setting up open innovation in drug development between industry and academia

•         Amer Alghbban, Director Global Quality Auditing, Merck Serono

Overcoming stringent regulatory barriers – accelerating drug approvals by meeting the requirements of ICH S4

Find out more at www.eddsummit.com 

Save £300 on your registration when booking on www.eddsummit.com/offer 

For further information or to book your place email Michaela Melcher, michaela.melcher@wtgevents.com or call +44(0)20 7202 7690



Further information
Scientific News
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!